Kaizen Advisory, LLC - SUPERNUS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Kaizen Advisory, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$630,000
-44.9%
18,946
-16.6%
0.44%
-26.6%
Q3 2018$1,144,000
-33.8%
22,721
-21.3%
0.60%
-32.0%
Q2 2018$1,727,000
+426.5%
28,857
+302.7%
0.88%
+171.0%
Q1 2018$328,000–7,165–0.32%–
 Download
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
EXCHANGE TRADED CONCEPTS, LLC 42,189$1,220,9500.03%
MASSMUTUAL TRUST CO FSB/ADV 320$9,2610.00%
Versant Capital Management, Inc 16$4630.00%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders